期刊
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
卷 105, 期 18, 页码 6649-6668出版社
SPRINGER
DOI: 10.1007/s00253-021-11539-w
关键词
Plant secondary metabolites; Plant tissue culture; Cell suspension; Hairy roots; Heterologous production
资金
- University of Vienna
Medicinal plants have been used for centuries, with bioactive plant secondary metabolites now serving as important drugs. Biotechnological manufacturing offers advantages over traditional methods, though commercialization is still in progress. Advances in biosynthetic pathway elucidation and genetic manipulation show promise for utilizing plant metabolic engineering.
Medicinal plants have been used by mankind since ancient times, and many bioactive plant secondary metabolites are applied nowadays both directly as drugs, and as raw materials for semi-synthetic modifications. However, the structural complexity often thwarts cost-efficient chemical synthesis, and the usually low content in the native plant necessitates the processing of large amounts of field-cultivated raw material. The biotechnological manufacturing of such compounds offers a number of advantages like predictable, stable, and year-round sustainable production, scalability, and easier extraction and purification. Plant cell and tissue culture represents one possible alternative to the extraction of phytochemicals from plant material. Although a broad commercialization of such processes has not yet occurred, ongoing research indicates that plant in vitro systems such as cell suspension cultures, organ cultures, and transgenic hairy roots hold a promising potential as sources for bioactive compounds. Progress in the areas of biosynthetic pathway elucidation and genetic manipulation has expanded the possibilities to utilize plant metabolic engineering and heterologous production in microorganisms. This review aims to summarize recent advances in the in vitro production of high-value plant secondary metabolites of medicinal importance.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据